How do I contact Ibrance for support?
For live personalized support, call 1-844-9-IBRANCE. Commercially Insured? Resources for eligible patients with commercial, private, employer, or state health insurance marketplace coverage. Eligible, commercially insured patients may pay as little as $0 per month for IBRANCE.
What is Ibrance used to treat?
IBRANCE is indicated for the treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer in combination with: • an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men, or
How much does it cost to enroll in Ibrance?
Eligible patients may pay as little as $0 per month for IBRANCE, regardless of income. There are no income requirements, forms, or faxing to enroll. Patients may receive up to $25,000 in savings annually.*.
What is the recommended dose of Ibrance for hepatic impairment?
For patients with severe hepatic impairment (Child-Pugh class C), the recommended dose of IBRANCE is 75 mg. The pharmacokinetics of IBRANCE have not been studied in patients requiring hemodialysis . Please see full Prescribing Information for IBRANCE capsules and tablets.
What is the Pfizer patient Assistance Program?
Pfizer Patient Assistance Program Provides free Pfizer medicines to eligible patients through their doctor's office or at home. To qualify, patients must: Have a valid prescription for the Pfizer medicine for which they are seeking assistance.
What is the copay for Ibrance?
With this card, eligible patients will pay a $0 co-pay per eligible monthly prescription, subject to a maximum amount of $25,000 per calendar year. The amount of any benefit is the difference between your co-pay and $0.
What is Pfizer Oncology together?
Pfizer Oncology Together is a personalized patient support program that offers resources for patients prescribed Pfizer Oncology medicines. We provide access and reimbursement support, as well as help identifying financial assistance options, so patients can get their prescribed Pfizer Oncology medicines.
Does Viatris have a patient assistance program?
The Viatris Patient Assistance Program provides certain medicines for free to patients with demonstrated financial need. Viatris is committed to helping patients get the treatments they need, when and where they need them.
How do people afford Ibrance?
As of March 2019, Ibrance is covered by 100% of Medicare Part D plans. However, your out-of-pocket cost may vary depending on your specific plan. Financial assistance through Extra Help, a Medicare Part D Low-Income Subsidy (LIS) program, may also be an option.
How much longer do you live with Ibrance?
For the 410 women who had responded to earlier hormonal therapy treatment, median overall survival was: 39.7 months for women treated with Ibrance and Faslodex. 29.7 months for women treated with Faslodex alone.
Who manufactures Ibrance?
IBRANCE® (palbociclib) Pfizer Oncology Together™ provides financial assistance resources to help patie…
What is Pfizer enCompass?
Pfizer enCompass offers various services to patients including reimbursement support for insured patients; co-pay assistance for eligible commercially insured patients who cannot afford their co-pays, co-insurances, or deductibles; and a free medicine patient assistance program for eligible uninsured or underinsured ...
What is on oncology?
A branch of medicine that specializes in the diagnosis and treatment of cancer.
Does Mylan have a patient assistance program?
Additional information about the Mylan EpiPen® (epinephrine injection, USP) Auto-Injector Patient Assistance Program is available by calling 800.796. 9526.
Does Pfizer own Viatris?
Viatris was formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our approximately 37,000 colleagues globally, we aim to deliver increased access to affordable, quality medicines for patients worldwide.
What is Viatris advocate?
The Viatris Advocate platform offers support and resources for patients, their caregivers and their healthcare providers.
When will Ibrance become generic?
Ibrance was eligible for patent challenges on February 3, 2019. By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be February 8, 2034.
Is Ibrance considered a chemotherapy drug?
IBRANCE® IS THE FIRST FDA-APPROVED MEDICATION in its class. IBRANCE is a targeted therapy known as a CDK 4/6 inhibitor. It is not a traditional chemotherapy. Taken in combination with certain hormonal therapies, IBRANCE works to put the brakes on cell growth in both healthy and cancer cells.
Is there a generic form of Ibrance?
No. There is currently no therapeutically equivalent version of Ibrance available in the United States. Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ibrance. These medications may be counterfeit and potentially unsafe.
What is the generic for Ibrance?
Palbociclib is the generic name for the trade name drug Ibrance. In some cases, health care professionals may use the trade name Ibrance when referring to the generic drug name palbociclib. Drug Type: Palbociclib is a targeted therapy.
Commercially Insured?
Resources for eligible patients with commercial, private, employer, or state health insurance marketplace coverage.
Co-Pay Assistance
Eligible, commercially insured patients may pay as little as $0 per month for IBRANCE. Limits, terms, and conditions apply.* There are no income requirements, forms, or faxing to enroll.
What is the dosage of IBRANCE?
IBRANCE (palbociclib) 125 mg capsules and tablets are indicated for the treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer (mBC) in combination with:
When to monitor blood count before starting IBRANCE?
Monitor complete blood count prior to starting IBRANCE, at the beginning of each cycle, on Day 15 of first 2 cycles and as clinically indicated. Dose interruption, dose reduction, or delay in starting treatment cycles is recommended for patients who develop Grade 3 or 4 neutropenia.
Can IBRANCE cause ILD?
Severe, life-threatening, or fatal interstitial lung disease (ILD) and/or pneumonitis can occur in patients treated with CDK4/6 inhibitors, including IBRANCE when taken in combination with endocrine therapy. Across clinical trials (PALOMA-1, PALOMA-2, PALOMA-3), 1.0% of IBRANCE-treated patients had ILD/pneumonitis of any grade, 0.1% had Grade 3 or 4, and no fatal cases were reported. Additional cases of ILD/pneumonitis have been observed in the post-marketing setting, with fatalities reported.
What is Pfizer Patient Assistance Program?
†The Pfizer Patient Assistance Program is a joint program of Pfizer Inc. and the Pfizer Patient Assistance Foundation™. The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc. with distinct legal restrictions.
How to contact Pfizer oncology?
If you are looking for financial assistance, call us at 1-877-744-5675. The Pfizer Oncology Together Co-Pay Savings Program (s) is/are available if you have been prescribed certain Pfizer Oncology oral or injectable medicines.*.
How long does Pfizer give free medicine?
If you're uninsured, you may receive free medicine for up to 1 calendar year. If you're underinsured, you'll be enrolled through the end of the calendar year.
Can you get free Pfizer oncology medicine?
Free medicine If support from independent charitable foundations or Extra Help is not available, we’ll see if you’re eligible for the Pfizer Patient Assistance Program, which can provide your prescribed Pfizer Oncology medicine for free. †
Does Pfizer provide financial assistance?
At Pfizer Oncology Together, we can connect you with financial assistance resources, regardless of your insurance coverage. Below are some materials you can download that may help you understand your healthcare coverage and insurance benefits. These materials may also provide you with more information if you're not sure what type of insurance you have.
What is an IBRANCE mentor?
The IBRANCE Ambassador Mentor Program offers patients taking IBRANCE—or their caregivers—the opportunity to have private, one-on-one phone conversations with an ambassador to share personal stories and experiences.
Is the Massachusetts prescription voucher valid?
This voucher is not valid for Massachusetts residents whose prescriptions are covered in whole or in part by third party insurance. This voucher is not valid where prohibited by law. This voucher cannot be combined with any other savings, free trial or similar offer for the specified prescription.
Does Pfizer provide financial assistance?
Pfizer is committed to supporting your patients throughout their treatment journey. With Pfizer Oncology Together™, patients prescribed IBRANCE get personalized support, including help identifying financial assistance options and connections to resources that may help with some of their day-to-day challenges.
Is the IBRANCE voucher a prescription?
This 1-month (21-day) voucher is not a prescription for IBRANCE.
What is the dosage of IBRANCE?
IBRANCE (palbociclib) 125 mg capsules and tablets are indicated for the treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer (mBC) in combination with:
When to monitor blood count before starting IBRANCE?
Monitor complete blood count prior to starting IBRANCE, at the beginning of each cycle, on Day 15 of first 2 cycles and as clinically indicated. Dose interruption, dose reduction, or delay in starting treatment cycles is recommended for patients who develop Grade 3 or 4 neutropenia.
Can IBRANCE cause ILD?
Severe, life-threatening, or fatal interstitial lung disease (ILD) and/or pneumonitis can occur in patients treated with CDK4/6 inhibitors, including IBRANCE when taken in combination with endocrine therapy. Across clinical trials (PALOMA-1, PALOMA-2, PALOMA-3), 1.0% of IBRANCE-treated patients had ILD/pneumonitis of any grade, 0.1% had Grade 3 or 4, and no fatal cases were reported. Additional cases of ILD/pneumonitis have been observed in the post-marketing setting, with fatalities reported.
